Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

SMITH DEVYN — Sigilon Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / SMITH DEVYN

SMITH DEVYN

CHIEF OPERATING OFFICER at Sigilon Therapeutics, Inc. · on record since Dec 3, 2020

Insider trading activity of SMITH DEVYN

Transactions on record: 1; since Feb 16, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 16, 2021

Figures computed from official regulatory filings — methodology.

Companies where SMITH DEVYN has traded

Sigilon Therapeutics, Inc.1 tx · Feb 16, 2021

Track record of SMITH DEVYN

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of SMITH DEVYN

Co-insiders of SMITH DEVYN

AFEYAN NOUBARSigilon Therapeutics, Inc.
ANDERSON DANIEL GRIFFITHSigilon Therapeutics, Inc.
Ashton-Rickardt PhilipSigilon Therapeutics, Inc.
Cole Douglas G.Sigilon Therapeutics, Inc.
CORZO DEYASigilon Therapeutics, Inc.
COX JOHNSigilon Therapeutics, Inc.
Flagship Pioneering Special Opportunities Fund II General Partner LLCSigilon Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Flagship Pioneering Special Opportunities Fund II, L.P.Sigilon Therapeutics, Inc.

Flagship Ventures Fund V General Partner LLCSigilon Therapeutics, Inc.

Flagship Ventures Fund V, L.P.Sigilon Therapeutics, Inc.

Flagship Ventures Management, Inc.Sigilon Therapeutics, Inc.

Kowalsky Matthew PaulSigilon Therapeutics, Inc.

LILLY ELI & COSigilon Therapeutics, Inc.

OESTERLE STEPHEN NSigilon Therapeutics, Inc.

Orfali MaySigilon Therapeutics, Inc.

Patel KavitaSigilon Therapeutics, Inc.

Pontes JosiasSigilon Therapeutics, Inc.

Reicin GlennSigilon Therapeutics, Inc.

RUFFOLO ROBERT RSigilon Therapeutics, Inc.

Shaff Eric D.Sigilon Therapeutics, Inc.

Shenandoah Acquisition CorpSigilon Therapeutics, Inc.

Story BrookeSigilon Therapeutics, Inc.

Vivaldi Coelho RogerioSigilon Therapeutics, Inc.

Yuan Qing SarahSigilon Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Sigilon Therapeutics, Inc.	Feb 16, 2021	AwardD	95,000	0.00 USD	$0	SEC